The Future of Lymphoma Therapy: Expert Perspectives on Breakthroughs and New Combinations
Wednesday, January 29th
3 p.m. PST. /. 6 p.m. EST
3 p.m. PST. /. 6 p.m. EST
Explore advancements in treatment with two lymphoma experts, Dr. Andrew Evens (Rutgers Cancer Institute) and Dr. Tycel Phillips (City of Hope).
Moderated by Stephanie Chuang, a non-Hodgkin lymphoma survivor and founder of The Patient Story, this program dives into the latest research, treatments, and strategies to empower patients and caregivers. Gain valuable insights including promising clinical trial results, breakthrough therapies, and personalized treatment options.
- Discover breakthrough treatments reshaping care for DLBCL and follicular lymphoma.
- Understand cutting-edge combinations like CAR T-cell therapy, antibody-drug conjugates, and bispecifics.
- Learn to balance effectiveness and quality of life with insights into side effects and survivorship.
- Access guidance on clinical trials, emerging therapies, and personalized medicine.
- Hear directly from leading experts about what’s next in lymphoma research and care.
Program Speakers
Andrew Evens, DO, MBA, MSc
Hematologist-Oncologist
Rutgers Cancer Institute
Tycel Phillips, MD
Hematologist-Oncologist
City of Hope - Duarte Cancer Center
Stephanie Chuang
Host, Cancer Survivor, and Founder
The Patient Story
Thank you to The Leukemia & Lymphoma Society for their partnership. The Leukemia & Lymphoma Society is here for you with information about clinical trials, resources, and support.
Thank you to AbbVie and Genmab for their support of our patient education program! The Patient Story retains full editorial control over all content.
